BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22110238)

  • 1. Prognostic significance of TIMP-1 in non-small cell lung cancer.
    Pesta M; Kulda V; Kucera R; Pesek M; Vrzalova J; Liska V; Pecen L; Treska V; Safranek J; Prazakova M; Vycital O; Bruha J; Holubec L; Topolcan O
    Anticancer Res; 2011 Nov; 31(11):4031-8. PubMed ID: 22110238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
    Safranek J; Pesta M; Holubec L; Kulda V; Dreslerova J; Vrzalova J; Topolcan O; Pesek M; Finek J; Treska V
    Anticancer Res; 2009 Jul; 29(7):2513-7. PubMed ID: 19596921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR.
    Simi L; Andreani M; Davini F; Janni A; Pazzagli M; Serio M; Orlando C
    Lung Cancer; 2004 Aug; 45(2):171-9. PubMed ID: 15246188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP1 and adverse prognosis in non-small cell lung cancer.
    Fong KM; Kida Y; Zimmerman PV; Smith PJ
    Clin Cancer Res; 1996 Aug; 2(8):1369-72. PubMed ID: 9816309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer.
    Suemitsu R; Yoshino I; Tomiyasu M; Fukuyama S; Okamoto T; Maehara Y
    Surg Today; 2004; 34(11):896-901. PubMed ID: 15526122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer.
    Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Danenberg KD; Danenberg PV; Hölscher AH; Brabender J
    Clin Lung Cancer; 2010 Mar; 11(2):114-9. PubMed ID: 20199977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.
    Ylisirniö S; Höyhtyä M; Mäkitaro R; Pääakkö P; Risteli J; Kinnula VL; Turpeenniemi-Hujanen T; Jukkola A
    Clin Cancer Res; 2001 Jun; 7(6):1633-7. PubMed ID: 11410500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.
    Vilmar A; Santoni-Rugiu E; Cillas JG; Huarriz M; Sørensen JB
    Anticancer Res; 2014 Jun; 34(6):2991-6. PubMed ID: 24922664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
    Sueoka E; Sueoka N; Iwanaga K; Sato A; Suga K; Hayashi S; Nagasawa K; Nakachi K
    Lung Cancer; 2005 Apr; 48(1):77-83. PubMed ID: 15777973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery.
    Dai CH; Li J; Shi SB; Yu LC; Ge LP; Chen P
    Jpn J Clin Oncol; 2010 Apr; 40(4):327-35. PubMed ID: 20056675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
    Safranek J; Holubec L; Topolcan O; Pesta M; Klecka J; Vodicka J; Finek J; Kormunda S; Pesek M
    Anticancer Res; 2007; 27(4C):2953-6. PubMed ID: 17695477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers.
    Välk K; Vooder T; Kolde R; Reintam MA; Petzold C; Vilo J; Metspalu A
    Oncology; 2010; 79(3-4):283-92. PubMed ID: 21412013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
    Marchetti A; Bertacca G; Buttitta F; Chella A; Quattrocolo G; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.
    Navarro A; Diaz T; Gallardo E; Viñolas N; Marrades RM; Gel B; Campayo M; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
    J Surg Oncol; 2011 Apr; 103(5):411-5. PubMed ID: 21400525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.